Multiple Sclerosis Linked to 3 Genes in Studies; More Likely
Bloomberg - USA
The research also could prompt new interest in developing Roche Holding AG's Zenapax, a drug that blocks the action of one of the genes, said researchers ...
See all stories on this topic

Elan says its loss widened in the second quarter
Boston Globe - United States
Cooke also said the company's multiple sclerosis drug Tysabri had a "solid quarter" with about 14000 patients on therapy as of mid-July -- an increase of ...
See all stories on this topic